- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.4: 16 residues within 4Å:- Chain A: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain B: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.1, POV.5, POV.6, POV.19, POV.20
13 PLIP interactions:8 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:I.969, A:F.970, A:F.970, A:F.970, B:W.1070, B:W.1070, B:L.1071, B:F.1074, B:L.1075
- Hydrogen bonds: A:Y.922, A:S.926
- Water bridges: A:S.926, A:F.970
CLR.24: 16 residues within 4Å:- Chain B: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain C: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.21, POV.25, POV.26, POV.36, POV.37
14 PLIP interactions:9 interactions with chain B, 5 interactions with chain C- Hydrophobic interactions: B:L.966, B:I.969, B:F.970, B:F.970, B:F.970, C:W.1070, C:W.1070, C:L.1071, C:F.1074, C:L.1075
- Hydrogen bonds: B:Y.922, B:S.926
- Water bridges: B:S.926, B:F.970
CLR.41: 16 residues within 4Å:- Chain C: Y.922, S.926, L.966, I.969, F.970, V.973
- Chain D: W.1070, L.1071, F.1074, L.1075, V.1078
- Ligands: POV.38, POV.42, POV.43, POV.53, POV.54
13 PLIP interactions:8 interactions with chain C, 5 interactions with chain D- Hydrophobic interactions: C:I.969, C:F.970, C:F.970, C:F.970, D:W.1070, D:W.1070, D:L.1071, D:F.1074, D:L.1075
- Hydrogen bonds: C:Y.922, C:S.926
- Water bridges: C:S.926, C:F.970
CLR.58: 16 residues within 4Å:- Chain A: W.1070, L.1071, F.1074, L.1075, V.1078
- Chain D: Y.922, S.926, L.966, I.969, F.970, V.973
- Ligands: POV.15, POV.16, POV.55, POV.59, POV.60
13 PLIP interactions:5 interactions with chain A, 8 interactions with chain D- Hydrophobic interactions: A:W.1070, A:W.1070, A:L.1071, A:F.1074, A:L.1075, D:L.966, D:I.969, D:F.970, D:F.970
- Hydrogen bonds: D:Y.922, D:S.926
- Water bridges: D:S.926, D:F.970
- 8 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
DU0.11: 19 residues within 4Å:- Chain A: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Chain D: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Ligands: POV.10, POV.20, POV.50, DU0.51
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.863, D:T.870, D:F.871
DU0.13: 8 residues within 4Å:- Chain A: M.867, L.868, F.871, Q.884
- Chain B: P.1027
- Ligands: POV.9, POV.30, DU0.31
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:M.867, A:L.868, A:F.871, B:P.1027
- Hydrogen bonds: A:Q.884
DU0.31: 19 residues within 4Å:- Chain A: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain B: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.12, DU0.13, POV.30, POV.37
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.863, A:T.870, A:F.871
DU0.33: 8 residues within 4Å:- Chain B: M.867, L.868, F.871, Q.884
- Chain C: P.1027
- Ligands: POV.29, DU0.34, POV.47
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:M.867, B:L.868, B:F.871, C:P.1027
- Hydrogen bonds: B:Q.884
DU0.34: 19 residues within 4Å:- Chain B: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain C: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.32, DU0.33, POV.47, POV.54
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.863, B:T.870, B:F.871
DU0.49: 8 residues within 4Å:- Chain C: M.867, L.868, F.871, Q.884
- Chain D: P.1027
- Ligands: POV.46, POV.64, DU0.65
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:M.867, C:L.868, C:F.871, D:P.1027
- Hydrogen bonds: C:Q.884
DU0.51: 8 residues within 4Å:- Chain A: P.1027
- Chain D: M.867, L.868, F.871, Q.884
- Ligands: POV.10, DU0.11, POV.63
5 PLIP interactions:4 interactions with chain D, 1 interactions with chain A- Hydrophobic interactions: D:M.867, D:L.868, D:F.871, A:P.1027
- Hydrogen bonds: D:Q.884
DU0.65: 19 residues within 4Å:- Chain C: L.863, L.866, M.867, T.870, F.871, L.874, Y.972, L.975
- Chain D: L.1011, P.1027, S.1028, W.1029, L.1031, A.1032, I.1035
- Ligands: POV.16, POV.48, DU0.49, POV.64
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.863, C:T.870, C:F.871
- 1 x CA: CALCIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 52 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 8 x DU0: 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol(Non-covalent)
- 1 x CA: CALCIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nadezhdin, K.D. et al., Structural mechanisms of TRPM7 activation and inhibition. Nat Commun (2023)
- Release Date
- 2023-05-17
- Peptides
- Transient receptor potential cation channel subfamily M member 7: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.